A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies
Clinical trial NCT02966171 · TERMINATED
Trial details
- NCT number
- NCT02966171
- Sponsor
- Hutchison Medipharma Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2018-08-23
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.